Custom service

Lipidation-Based Long-Acting Peptide Design Services

Design lipidation-based long-acting peptide constructs for extended dosing

Turnaround: 6–10 weeksTypical scale: mg – g design batchesChemistry options: albumin-binder lipid motif design; dosing-interval modeling; potency-preserving modification sites

The service is built around albumin-binder lipid motif design. Depending on the molecule we may move to dosing-interval modeling or potency-preserving modification sites to improve stability, loading or yield, and every batch is released with designed constructs with stability and potency data.

Because Lipidation-Based Long-Acting Peptide Designs projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.

Weekly-dosing peptide concepts

Half-life extension without receptor loss

Depot-mechanism (formulation-led) extension programmes

Programs expecting in-vivo efficacy guarantees from chemistry services

Platform outputs include the design rationale, analytical release of the modified peptide, and in-vitro release/stability datasets that support the chosen dosing concept.

Service Highlights

  • Albumin-binder lipid motif design as the default route, with dosing-interval modeling held as a proven fallback
  • Potency-preserving modification sites worked into the design where the application requires it
  • Half-life strategy selected against the dosing objective (weekly vs monthly), not by fashion
  • Analytical confirmation of every intermediate before the final release
  • In-vitro release and stability data generated before any in-vivo claim is discussed
  • Designed constructs with stability and potency data delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Dosing objective review

    Target dosing interval and route define the Lipidation-Based Long-Acting Peptide Design Services design space.

  2. Extension strategy design

    albumin-binder lipid motif design and alternatives are modeled against receptor-binding constraints.

  3. Synthesis & modification

    Candidate constructs are synthesized with dosing-interval modeling.

  4. In-vitro evaluation

    Serum stability, albumin binding and potency are measured across candidates.

  5. Selection & refinement

    The lead construct is refined until stability and potency meet the target.

  6. Release

    Designed constructs with stability and potency data plus the design dossier is delivered.

Specifications & timeline

Turnaround
6–10 weeks
Typical scale
mg – g design batches
Chemistry options
albumin-binder lipid motif design; dosing-interval modeling; potency-preserving modification sites
Deliverable
Designed constructs with stability and potency data
QC package
Design dossier, analytical release, in-vitro release data
Shipping
Blue ice with stability handling notes

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.